Matthew Shea
Stock Analyst at Needham
(3.34)
# 2,401
Out of 5,023 analysts
42
Total ratings
53.6%
Success rate
9.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Matthew Shea
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASTH Astrana Health | Reiterated: Buy | $41 | $35.88 | +14.27% | 4 | Aug 7, 2026 | |
| STLN Starling Oncology | Reiterated: Buy | $7 | $6.35 | +10.24% | 10 | Aug 7, 2026 | |
| AGL agilon health | Reiterated: Hold | n/a | $84.14 | - | 9 | Aug 6, 2026 | |
| EVH Evolent Health | Reiterated: Buy | $5 | $3.46 | +44.51% | 12 | Aug 6, 2026 | |
| PRVA Privia Health Group | Reiterated: Buy | $30 | $20.30 | +47.78% | 7 | May 7, 2026 |
Astrana Health
Aug 7, 2026
Reiterated: Buy
Price Target: $41
Current: $35.88
Upside: +14.27%
Starling Oncology
Aug 7, 2026
Reiterated: Buy
Price Target: $7
Current: $6.35
Upside: +10.24%
agilon health
Aug 6, 2026
Reiterated: Hold
Price Target: n/a
Current: $84.14
Upside: -
Evolent Health
Aug 6, 2026
Reiterated: Buy
Price Target: $5
Current: $3.46
Upside: +44.51%
Privia Health Group
May 7, 2026
Reiterated: Buy
Price Target: $30
Current: $20.30
Upside: +47.78%